Get startedLog in
    Picture of Larimar Therapeutics logo

    LRMR — Larimar Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Larimar Therapeutics Q3 Net Income USD -47.712 Million

    Picture of Larimar Therapeutics logoLarimar Therapeutics
    05/11/2025 12:00
    Nov 05 (Reuters) - Larimar Therapeutics Q3 operating expenses USD 49.499 million.

Q3 basic EPS USD -0.61

Q3 income from operations USD -49.499 million

Q3 EPS USD -0.61

    Recent news on Larimar Therapeutics

    See all news